Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF

AIM: Patients hospitalized for acute heart failure (AHF) differ with respect of many clinical characteristics which may influence their prognosis and response to treatment. We have assessed possible differences in the effects of serelaxin on dyspnoea relief, 60 Day outcomes and 180 Day mortality acr...

Descripción completa

Detalles Bibliográficos
Autores principales: Metra, Marco, Ponikowski, Piotr, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H., Hua, Tsushung A., Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Teerlink, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Esc Fasttrack
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800849/
https://www.ncbi.nlm.nih.gov/pubmed/23999454
http://dx.doi.org/10.1093/eurheartj/eht371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800849/
https://www.ncbi.nlm.nih.gov/pubmed/23999454
http://dx.doi.org/10.1093/eurheartj/eht371

Ejemplares similares